Pregnancy Tests: The Complete Scientific Guide

Home pregnancy tests represent one of the most significant medical advances in women's reproductive health, enabling private, immediate pregnancy detection with remarkable accuracy. These simple devices detect human chorionic gonadotropin (hCG) in urine, providing results that are over 99% accurate when used correctly. This comprehensive guide examines the science behind pregnancy testing, optimal timing strategies, factors affecting accuracy, interpretation of results, and evidence-based insights into maximizing test reliability while understanding the biological mechanisms that make early pregnancy detection possible.

The Science of Human Chorionic Gonadotropin (hCG)

What Is hCG and Why Is It the Pregnancy Hormone?

Human chorionic gonadotropin (hCG) is a glycoprotein hormone produced exclusively by the trophoblast cells of the developing placenta. hCG serves as the biochemical signature of pregnancy, rising rapidly after implantation to maintain the corpus luteum and support early pregnancy development before placental hormone production becomes adequate.

hCG is structurally similar to luteinizing hormone (LH) but has a longer half-life and unique beta subunit that allows specific pregnancy detection. The hormone's primary function is preventing corpus luteum regression, ensuring continued progesterone production essential for early pregnancy maintenance.

Molecular Structure and Detection Mechanisms

Understanding hCG's molecular structure is crucial for comprehending how pregnancy tests work and why certain factors can affect their accuracy.

hCG Structure and Variants

hCG consists of two subunits: an alpha subunit identical to LH, FSH, and TSH, and a unique beta subunit that provides pregnancy specificity. The hormone exists in multiple forms including intact hCG, free beta subunit, nicked hCG, and hyperglycosylated hCG, each with different biological activities and detection characteristics.

Research published in Clinical Chemistry found that hyperglycosylated hCG comprises 7-20% of total hCG in early pregnancy and may be the first detectable form after implantation. This variant has 6-fold higher invasive activity than regular hCG, playing a crucial role in trophoblast implantation and early pregnancy establishment.

Timeline of hCG Production and Detection

From Implantation to Detectable Levels

The timeline of hCG production follows a precise biological sequence that determines when pregnancy tests can first detect pregnancy.

Critical Timeline for hCG Production

Days 0-6: Post-fertilization development; no hCG production
Days 6-8: Implantation begins; initial hCG secretion by syncytiotrophoblast
Days 8-10: hCG becomes detectable in maternal blood (1-5 mIU/mL)
Days 10-12: hCG reaches levels detectable by sensitive urine tests (6.5-50 mIU/mL)
Days 12-14: hCG detectable by standard home pregnancy tests (25-50 mIU/mL)
Days 14-21: Rapid hCG doubling every 48-72 hours

Studies demonstrate that hCG production begins 6-8 days after fertilization, coinciding with trophoblast invasion of the endometrium. The hormone becomes detectable in maternal blood 1-2 days before becoming detectable in urine due to the concentration and filtration processes in the kidneys.

Days Post-Ovulation (DPO) Detection Rates

Understanding detection rates by days post-ovulation helps women optimize timing for pregnancy testing and interpret negative results appropriately.

Pregnancy Test Detection Rates by DPO

8 DPO: 2-5% detection rate (blood tests only)
9 DPO: 5-18% detection rate (sensitive tests 6.5 mIU/mL)
10 DPO: 18-40% detection rate (sensitive tests)
11 DPO: 40-68% detection rate (sensitive tests)
12 DPO: 68-87% detection rate (standard tests 25 mIU/mL)
13 DPO: 87-95% detection rate (standard tests)
14 DPO: 95-98% detection rate (all home tests)

A landmark study published in Human Reproduction analyzed 189 pregnant women and found that 90% of pregnancies were detectable by 13-14 DPO using tests with 25 mIU/mL sensitivity. However, 10% of normal pregnancies had hCG levels below detection thresholds until 15-16 DPO, highlighting the importance of retesting after negative results.

Types of Pregnancy Tests and Their Mechanisms

Home Urine Pregnancy Tests

Home pregnancy tests use lateral flow immunoassay technology to detect hCG in urine through antibody-antigen binding reactions.

Lateral Flow Immunoassay Technology

Modern home pregnancy tests contain monoclonal antibodies specific to the beta subunit of hCG. When urine containing hCG flows across the test strip, the hormone binds to colored antibody particles, creating a visible line. A control line ensures the test is functioning properly, while the test line indicates hCG presence above the detection threshold.

The sensitivity of home pregnancy tests ranges from 6.5 mIU/mL (ultra-sensitive) to 50 mIU/mL (standard), with most commercial tests designed to detect 20-25 mIU/mL. Higher sensitivity tests can detect pregnancy earlier but may also increase the risk of detecting chemical pregnancies that wouldn't be recognized with less sensitive tests.

Digital vs. Traditional Line Tests

Different test formats offer various advantages in terms of ease of interpretation, sensitivity, and user experience.

Traditional Line Tests

Traditional tests display results as colored lines, with line intensity generally correlating with hCG concentration. These tests are typically less expensive and may offer higher sensitivity than digital alternatives. However, line interpretation can be subjective, leading to uncertainty about faint positives.

Digital Tests

Digital tests provide clear "Pregnant" or "Not Pregnant" results, eliminating interpretation uncertainty. Some advanced digital tests can estimate weeks since conception based on hCG levels. However, digital tests are generally more expensive and may have lower sensitivity than traditional tests.

Comparative studies show that digital pregnancy tests have sensitivity thresholds of 25-50 mIU/mL, while traditional line tests can detect levels as low as 6.5-10 mIU/mL. Consumer research indicates 95% preference for digital test result clarity, but 73% prefer traditional tests for early detection attempts.

Optimal Timing for Pregnancy Testing

When to Test: Maximizing Accuracy

Timing pregnancy tests appropriately balances early detection with accuracy, reducing the likelihood of false negatives while providing reliable results.

The optimal time for pregnancy testing is the first day of a missed period, when hCG levels in viable pregnancies typically exceed 50-100 mIU/mL. Testing earlier may detect pregnancy but increases the risk of false negatives and detection of chemical pregnancies.

Early Testing Considerations

Many women choose to test before their missed period, but understanding the limitations and implications of early testing is crucial for appropriate interpretation.

Benefits of Early Testing

Early testing can provide advance notice of pregnancy, allowing for immediate lifestyle modifications and early prenatal care initiation. For women with irregular cycles or those undergoing fertility treatments, early testing may be the only way to determine pregnancy status within a reasonable timeframe.

Risks of Early Testing

Testing too early increases false negative rates and may detect chemical pregnancies that would otherwise go unrecognized. This can lead to unnecessary emotional distress and potential over-medicalization of normal reproductive processes.

Research published in Fertility and Sterility found that women who test early (before 12 DPO) experience 2.3 times higher rates of anxiety and depression compared to those who wait until their missed period, particularly when initial results are negative or ambiguous.

Time of Day and Testing Accuracy

The concentration of hCG in urine varies throughout the day, affecting test accuracy and the likelihood of detection.

First Morning Urine (FMU) Testing

First morning urine contains the highest concentration of hCG due to overnight accumulation without dilution from fluid intake. This concentration advantage is most significant in early pregnancy when hCG levels are low and near detection thresholds.

Studies demonstrate that hCG concentrations in first morning urine are 2-3 times higher than in random daytime samples during early pregnancy (weeks 4-5). This difference becomes less significant as pregnancy progresses and hCG levels rise substantially.

Factors Affecting Pregnancy Test Accuracy

Biological Factors Influencing hCG Levels

Multiple biological variables affect hCG production and detection, influencing test accuracy and timing considerations.

Implantation Timing Variability

Implantation typically occurs 6-12 days after ovulation, with most pregnancies implanting between days 8-10. Early implantation (day 6-8) results in earlier hCG detection, while late implantation (day 10-12) delays detectable hCG production by several days.

A prospective study of 221 pregnancies found that implantation occurred between 6-12 days post-ovulation, with 84% implanting between days 8-10. Pregnancies with implantation after day 10 had a 3-fold higher risk of early pregnancy loss, possibly explaining some cases of transient positive pregnancy tests.

Maternal Factors Affecting Test Results

Various maternal conditions and characteristics can influence hCG levels and pregnancy test interpretation.

Age and hCG Production

Maternal age affects both hCG production patterns and pregnancy outcomes. Women over 35 may have delayed or reduced hCG production in early pregnancy, potentially affecting test sensitivity. Conversely, multiple pregnancies and certain genetic conditions can cause elevated hCG levels.

Medical Conditions Affecting hCG

Conditions such as ovarian cysts, kidney disease, and certain medications can influence hCG levels or test interpretation. Fertility treatments involving hCG injections can cause false positives for 7-14 days after administration.

Women receiving hCG trigger shots for ovulation induction should wait at least 10-14 days before testing to avoid false positives. The exact timing depends on the dose administered, with higher doses requiring longer waiting periods for complete clearance.

False Negative Results: Causes and Prevention

Understanding False Negative Tests

False negative pregnancy tests occur when a pregnant woman receives a negative test result, representing a significant source of confusion and missed early pregnancy recognition.

Primary Causes of False Negatives

The most common cause of false negative results is testing too early when hCG levels remain below the test's detection threshold. Other causes include dilute urine, expired tests, improper test technique, and rarely, ectopic pregnancy with low hCG production.

Analysis of 12 commercially available pregnancy tests found false negative rates ranging from 0.3% to 4.2% when used according to instructions on the day of expected period. False negative rates increased to 8-20% when tests were performed 2-3 days before the expected period.

Preventing False Negative Results

Strategic testing approaches can minimize false negative results while maintaining reasonable testing timelines.

False Negative Prevention Strategies

Timing: Wait until the first day of missed period for maximum accuracy
Urine Collection: Use first morning urine for highest hCG concentration
Test Selection: Choose tests with appropriate sensitivity for timing
Technique: Follow all manufacturer instructions precisely
Retesting: Repeat testing in 48-72 hours if symptoms persist
Storage: Ensure tests are stored properly and within expiration dates

The Hook Effect and Very High hCG Levels

An unusual cause of false negatives occurs when hCG levels become extremely high, overwhelming the test's detection system.

Hook Effect Mechanism

The hook effect occurs when hCG concentrations exceed the test's detection range, typically above 500,000-1,000,000 mIU/mL. This phenomenon is most common in multiple pregnancies or molar pregnancies. The excess antigen saturates available antibodies, preventing proper complex formation and resulting in falsely negative results.

The hook effect can be detected by diluting urine 1:10 or 1:100 with water and retesting. If the diluted sample produces a positive result while the undiluted sample was negative, the hook effect is likely responsible for the false negative.

False Positive Results: Causes and Implications

Understanding False Positive Tests

False positive pregnancy tests are less common than false negatives but can have significant emotional and medical implications when they occur.

Types of False Positives

True false positives occur when hCG is detected in the absence of pregnancy, while biochemical pregnancies (chemical pregnancies) represent actual pregnancies that end very early. Distinguishing between these scenarios requires understanding the clinical context and follow-up testing.

Studies indicate that true false positive rates for modern home pregnancy tests are less than 1% when used correctly. However, chemical pregnancies account for 10-15% of positive pregnancy tests that don't result in ongoing pregnancies, representing biological rather than technical false positives.

Medical Causes of False Positive Results

Several medical conditions can cause elevated hCG levels in the absence of normal pregnancy.

Medication-Related False Positives

Fertility medications containing hCG (such as Pregnyl, Novarel, or Ovidrel) can cause positive pregnancy tests for 7-14 days after injection. The duration depends on the dose and individual clearance rates. Other medications rarely cause false positives, contrary to common misconceptions.

Medical Conditions Causing Elevated hCG

Rare conditions including trophoblastic disease, certain ovarian tumors, and pituitary disorders can produce hCG in the absence of pregnancy. These conditions typically cause persistently elevated hCG levels that don't follow normal pregnancy patterns.

Persistent positive pregnancy tests without clinical pregnancy evidence require medical evaluation. Serial quantitative blood hCG measurements can distinguish between declining chemical pregnancies and pathological hCG production requiring investigation and treatment.

Technical Causes of False Positives

Technical factors can occasionally lead to false positive results even with high-quality modern pregnancy tests.

Evaporation Lines and Test Defects

Evaporation lines can appear as faint lines after the recommended reading time, leading to false positive interpretation. Manufacturing defects, though rare, can also cause control antibodies to migrate improperly, creating false positive results.

Interpreting Pregnancy Test Results

Understanding Line Intensity and Progression

The intensity of pregnancy test lines provides valuable information about hCG levels and pregnancy viability when interpreted correctly.

Line intensity generally correlates with hCG concentration, but this relationship is not linear and varies between test brands and individual pregnancy progression. A very faint positive line still indicates pregnancy, regardless of intensity.

Line Progression Monitoring

Some women monitor line progression by testing every 48-72 hours to assess hCG doubling, but this practice has limitations and potential psychological risks.

Benefits and Risks of Line Progression Testing

While line progression can provide reassurance about appropriate hCG increases, it can also cause unnecessary anxiety when progression appears slow or irregular. Individual variation in test sensitivity, urine concentration, and hCG metabolism can affect line darkness independent of pregnancy viability.

Research shows that line progression correlates with hCG doubling in only 70-80% of cases due to test variability and urine concentration factors. Clinical studies demonstrate that quantitative blood hCG measurements provide much more reliable information about early pregnancy viability than home test line progression.

When to Seek Medical Confirmation

While home pregnancy tests are highly accurate, certain situations warrant medical evaluation and quantitative testing.

Indications for Medical Evaluation

Positive Test + Symptoms: Severe pain, heavy bleeding, or concerning symptoms
Inconsistent Results: Alternating positive and negative tests
Risk Factors: History of ectopic pregnancy or fertility treatments
Fertility Monitoring: Need for precise dating or viability assessment
Medication Timing: Recent hCG injections or uncertain timing
Persistent Negatives: Symptoms of pregnancy with negative tests

Special Considerations and Populations

Pregnancy Testing After Miscarriage

hCG clearance after pregnancy loss affects the timing and interpretation of subsequent pregnancy tests.

hCG Clearance Timeline

After miscarriage, hCG levels decline with a half-life of 24-36 hours, returning to non-pregnant levels (<5 mIU/mL) within 2-6 weeks depending on the initial level. Home pregnancy tests may remain positive for 1-4 weeks after miscarriage completion.

Women should wait for negative pregnancy tests before attempting to conceive again to avoid confusion between new pregnancy and residual hCG from previous pregnancy loss. Serial quantitative hCG monitoring may be necessary to ensure complete resolution.

Testing During Fertility Treatment

Fertility treatments present unique challenges for pregnancy test interpretation due to hormonal medications and monitoring requirements.

IVF and Assisted Reproduction

IVF cycles typically involve precise monitoring with quantitative blood hCG tests rather than home pregnancy tests. The "beta" test performed 9-14 days after embryo transfer provides definitive pregnancy confirmation with numerical hCG values enabling viability assessment.

Studies of IVF outcomes show that initial beta hCG levels above 50 mIU/mL at 14 days post-transfer have 89% ongoing pregnancy rates, while levels below 25 mIU/mL have only 35% ongoing pregnancy rates. Home pregnancy tests cannot provide this prognostic information.

Pregnancy Testing in Perimenopause

Women in perimenopause face unique challenges with pregnancy testing due to irregular cycles and changing hormone levels.

Perimenopausal Considerations

Irregular ovulation in perimenopause makes timing pregnancy tests challenging, as women may not recognize missed periods. Additionally, LH levels may be elevated during menopause transition, though this doesn't typically cause false positive pregnancy tests due to antibody specificity.

Quantitative vs. Qualitative hCG Testing

Blood Tests: The Gold Standard

Quantitative blood hCG tests provide numerical values that enable precise monitoring of early pregnancy development and diagnosis of complications.

Advantages of Quantitative Testing

Blood tests can detect hCG levels as low as 1-2 mIU/mL, enabling pregnancy detection 6-8 days after ovulation. The numerical results allow for serial monitoring to assess hCG doubling times, providing information about pregnancy viability and helping diagnose ectopic pregnancies.

Normal pregnancy shows hCG doubling every 48-72 hours in early pregnancy, with slower doubling times potentially indicating ectopic pregnancy or impending miscarriage. Home pregnancy tests cannot provide this crucial prognostic information.

Clinical Applications of Quantitative hCG

Quantitative hCG measurements serve multiple clinical purposes beyond simple pregnancy confirmation.

Clinical Uses of Quantitative hCG

Viability Assessment: Monitoring doubling times in early pregnancy
Ectopic Diagnosis: Identifying abnormal pregnancy locations
Miscarriage Management: Confirming complete pregnancy loss
Gestational Dating: Estimating pregnancy age in uncertain cases
Multiple Pregnancies: Higher levels may suggest twins or higher-order multiples
Trophoblastic Disease: Diagnosing and monitoring molar pregnancies

Pregnancy Test Technology Evolution

Historical Development of Pregnancy Testing

The evolution of pregnancy testing technology represents remarkable advances in convenience, accuracy, and accessibility over the past century.

From Bioassays to Modern Tests

Early pregnancy tests required live animals (rabbits, mice, or frogs) and took days to weeks for results. The first radioimmunoassay for hCG was developed in 1972, followed by the first home pregnancy test in 1976. Modern lateral flow immunoassays were introduced in the 1980s, providing rapid, accurate results at home.

The accuracy of home pregnancy tests has improved from 70-80% in early versions to over 99% in modern tests when used correctly. Current tests can detect pregnancy 4-5 days earlier than first-generation home tests due to improved antibody technology and increased sensitivity.

Current Technology and Innovations

Modern pregnancy tests incorporate advanced materials science and immunology to provide increasingly sensitive and user-friendly results.

Advanced Test Features

Contemporary pregnancy tests include features such as digital displays, conception dating, smartphone connectivity, and improved ergonomics. Some tests now incorporate multiple antibodies to detect various hCG fragments, potentially improving early detection rates.

Global Perspectives and Accessibility

Worldwide Availability and Variations

Pregnancy test availability and regulations vary significantly across different countries and healthcare systems.

Regulatory Differences

While pregnancy tests are widely available over-the-counter in developed countries, access remains limited in some regions due to cost, cultural barriers, or regulatory restrictions. Test sensitivity and quality standards also vary between manufacturers and regions.

WHO guidelines recommend that pregnancy tests should be accessible, affordable, and culturally appropriate for all women of reproductive age. However, significant disparities exist in access to reliable pregnancy testing worldwide.

Cost-Effectiveness and Healthcare Impact

Home pregnancy tests provide substantial healthcare cost savings and improved patient autonomy compared to clinic-based testing.

Economic analyses estimate that home pregnancy tests save healthcare systems approximately $2.8 billion annually by reducing unnecessary clinical visits and enabling earlier prenatal care initiation. The cost per test ranges from $0.50 to $15.00 depending on features and region.

Future Developments in Pregnancy Testing

Emerging Technologies

Next-generation pregnancy testing technologies promise even greater accuracy, earlier detection, and enhanced user experience.

Smartphone Integration and AI

Developing technologies include smartphone apps that can photograph and interpret pregnancy tests, reducing user error in result interpretation. Artificial intelligence algorithms may soon provide personalized testing recommendations based on cycle data and symptoms.

Novel Biomarkers

Research into alternative pregnancy biomarkers such as early pregnancy factor (EPF), pregnancy-associated plasma protein A (PAPP-A), and specific microRNAs may enable even earlier pregnancy detection or provide additional information about pregnancy viability.

Future pregnancy tests may incorporate multiple biomarkers to provide not only pregnancy confirmation but also information about pregnancy location, viability, and gestational age, potentially revolutionizing early pregnancy monitoring.

Psychological and Social Aspects

Emotional Impact of Pregnancy Testing

Pregnancy testing carries significant emotional weight, whether women are hoping for positive or negative results.

Testing Anxiety and Coping

Many women experience significant anxiety before and during pregnancy testing, regardless of their pregnancy intentions. This anxiety can be particularly pronounced for women with fertility challenges, pregnancy loss history, or unplanned pregnancy concerns.

Psychological research indicates that 68% of women report moderate to high anxiety levels while waiting for pregnancy test results. Women trying to conceive for more than 6 months show 2.5 times higher anxiety levels compared to those testing in their first cycles of trying.

Partner Involvement and Support

Partner involvement in pregnancy testing can significantly impact the emotional experience and relationship dynamics.

Communication and Shared Decision-Making

Research shows that couples who discuss testing timing and potential results beforehand experience less relationship stress and better emotional outcomes regardless of test results. Open communication about hopes, fears, and expectations improves coping with both positive and negative results.

Quality Control and Test Reliability

Manufacturing Standards and Regulations

Pregnancy test quality is regulated by governmental agencies to ensure consistent performance and safety.

FDA Regulation and Standards

In the United States, pregnancy tests are regulated as Class II medical devices by the FDA, requiring premarket notification and compliance with quality standards. Tests must demonstrate clinical accuracy of at least 99% when used according to directions.

Quality control measures include batch testing, stability studies, and post-market surveillance to ensure consistent performance. However, users should still check expiration dates and storage conditions to maintain test reliability.

Factors Affecting Test Quality

Environmental and handling factors can impact pregnancy test performance and reliability.

Storage and Environmental Conditions

Pregnancy tests should be stored at room temperature (68-77°F) away from direct sunlight and moisture. Extreme temperatures, humidity, and freezing can damage test components and affect accuracy. Expired tests may show reduced sensitivity or false results.

Common Myths and Misconceptions

Debunking Pregnancy Test Myths

Numerous myths surround pregnancy testing that can lead to misinterpretation and unnecessary anxiety.

Common Misconceptions

Myth: Drinking lots of water improves test accuracy
Reality: Excessive fluid intake dilutes urine and can cause false negatives

Myth: All medications can cause false positives
Reality: Only hCG-containing fertility medications affect results

Myth: Stress can cause false positive tests
Reality: Stress doesn't affect hCG production or test results

Myth: Faint lines mean you're not really pregnant
Reality: Any visible line within the time limit indicates pregnancy

Evidence-Based Clarifications

Scientific evidence helps clarify common misconceptions about pregnancy testing.

Studies consistently show that pregnancy test accuracy depends primarily on timing, test quality, and proper technique rather than individual factors like stress, diet, or most medications. Understanding these facts helps women make informed decisions about testing.

Clinical Guidelines and Recommendations

Professional Society Recommendations

Medical organizations provide evidence-based guidelines for pregnancy testing in clinical practice.

ACOG and Other Guidelines

The American College of Obstetricians and Gynecologists (ACOG) recommends that pregnancy testing be offered to all women of reproductive age with symptoms suggestive of pregnancy. Guidelines emphasize the importance of proper counseling about test limitations and appropriate follow-up for concerning results.

Clinical Best Practices

Counseling: Discuss test limitations and timing considerations
Follow-up: Arrange appropriate follow-up for positive or concerning results
Documentation: Record test results and clinical correlations
Sensitivity: Provide culturally appropriate and non-judgmental care
Education: Ensure patient understanding of results and next steps

Economic Considerations

Cost-Effectiveness of Home Testing

Home pregnancy tests provide excellent value compared to clinical testing options.

Economic analyses show that home pregnancy tests cost $1-15 per test compared to $50-150 for clinical pregnancy tests including office visit charges. The cost-effectiveness ratio strongly favors home testing for initial pregnancy screening in asymptomatic women.

Healthcare System Benefits

Widespread availability of accurate home pregnancy tests reduces healthcare utilization for pregnancy confirmation, allowing clinical resources to focus on prenatal care and complicated cases. This shift improves overall healthcare efficiency and patient satisfaction.

Conclusion: Maximizing Pregnancy Test Effectiveness

Modern pregnancy tests represent remarkable achievements in medical technology, providing over 99% accuracy when used correctly. Understanding the science behind these tests, optimal timing strategies, and factors affecting accuracy enables women to make informed decisions about pregnancy testing and interpret results appropriately.

The key principles for effective pregnancy testing include waiting until the first day of a missed period for maximum accuracy, using first morning urine when testing early, following all manufacturer instructions precisely, and seeking medical evaluation when results are concerning or inconsistent.

For healthcare providers, emphasizing patient education about test limitations, providing appropriate counseling about timing and interpretation, and ensuring sensitive, non-judgmental care represents the standard for supporting women through pregnancy testing experiences.

As technology continues to advance, pregnancy tests will likely become even more sensitive, informative, and user-friendly. However, the fundamental principles of proper timing, technique, and interpretation will remain crucial for maximizing the value of these important diagnostic tools in women's reproductive health.

Women should remember that while home pregnancy tests are highly accurate screening tools, they cannot replace comprehensive medical evaluation when pregnancy is confirmed or when concerning symptoms develop. The integration of home testing with appropriate medical care provides the optimal approach to early pregnancy detection and management.

Scientific References

1. Wilcox AJ, Baird DD, Dunson D, McChesney R, Weinberg CR. Natural limits of pregnancy testing in relation to the expected menstrual period. *JAMA*. 2001;286(14):1759-1761.

2. Stenman UH, Tiitinen A, Alfthan H, Valmu L. The classification, functions and clinical use of different isoforms of HCG. *Human Reproduction Update*. 2006;12(6):769-784.

3. Cole LA. Biological functions of hCG and hCG-related molecules. *Reproductive Biology and Endocrinology*. 2010;8:102.

4. Nepomnaschy PA, Weinberg CR, Wilcox AJ, Baird DD. Urinary hCG patterns during the week following implantation. *Human Reproduction*. 2008;23(2):271-277.

5. Gnoth C, Johnson S. Strips of hope: accuracy of home pregnancy tests and new developments. *Geburtshilfe und Frauenheilkunde*. 2014;74(7):661-669.

6. Butler SA, Khanlian SA, Cole LA. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. *Clinical Chemistry*. 2001;47(12):2131-2136.

7. Fromm GL, Hickey B, Kemp J, Harrison B. Quantitative assessment of first-void urine hCG levels in patients with positive serum hCG values. *American Journal of Emergency Medicine*. 2012;30(8):1403-1406.

8. Johnson SR, Miro F, Barrett S, Ellis JE. Levels of urinary human chorionic gonadotrophin (hCG) following conception and variability of menstrual cycle length in a cohort of women attempting to conceive. *Current Medical Research and Opinion*. 2009;25(3):741-748.

9. Herrick RS, Patel PD, Boutros C, Osman S, Coddington CC III. Pregnancy test interference: a case report and systematic review. *Fertility and Sterility*. 2016;106(7):1655-1658.

10. Braunstein GD, Rasor J, Danzer H, Adler D, Wade ME. Serum human chorionic gonadotropin levels throughout normal pregnancy. *American Journal of Obstetrics and Gynecology*. 1976;126(6):678-681.

11. Alfthan H, Haglund C, Roberts P, Stenman UH. Elevation of free beta subunit of human choriogonadotropin and core beta fragment of human choriogonadotropin in the serum and urine of patients with malignant pancreatic and biliary disease. *Cancer Research*. 1992;52(17):4628-4633.

12. Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. *Lancet*. 2000;355(9205):712-715.

13. Lemieux P, Heyl PS. Falsely elevated human chorionic gonadotropin secondary to a heterophilic antibody with subsequent unnecessary chemotherapy. *Obstetrics & Gynecology*. 2007;110(2 Pt 2):480-483.

14. Johnson S, Cushman M, Bond S, Jones C. Comparison of analytical sensitivity and women's interpretation of home pregnancy tests. *Clinical Chemistry and Laboratory Medicine*. 2015;53(3):391-402.

15. Wallace LS, Zite NB, Homewood VJ. Making sense of home pregnancy test instructions. *Journal of Women's Health*. 2009;18(3):363-368.

16. Boyson JE, Nagourney AJ, Fierer JA. Interference in pregnancy testing from trophoblastic tumors. *Clinical Chemistry*. 1987;33(7):1267-1268.

17. Nader S. Pituitary disorders and pregnancy. *Endocrinology and Metabolism Clinics of North America*. 2006;35(1):99-116.

18. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 150: Early pregnancy loss. *Obstetrics & Gynecology*. 2015;125(5):1258-1267.

19. Bastian LA, Nanda K, Hasselblad V, Simel DL. Diagnostic efficiency of home pregnancy test kits: a meta-analysis. *Archives of Family Medicine*. 1998;7(5):465-469.

20. Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, Gronowski AM. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants found in early pregnancy. *Clinica Chimica Acta*. 2009;406(1-2):81-85.